The first EIC 2023 call closed on January 11, 2023 and results have been recently published:
- 32 companies have been funded by the EIC in the January 2023 call with a total budget of €195.8M,
- The top countries have been the Netherlands (22%), Sweden (9%), Denmark (9%) and Ireland (9%),
- Blended finance has been the most requested financing type (53.12%).
This first cut-off has come with several surprises: Only 476 applications were submitted showing a sharp decrease in the participation rate by 43% compared to the previous call). Besides, while the Step 2 success rate increased to 33.40% as 159 companies reached the interview, only 32 companies were finally funded (20% success rate). The interview has therefore become the most challenging step in the last call. The reasons for this change in success rates have not been made public by the EIC.
The upward trend in female winners is consolidating as 40% percent of the winners (13 of the 32 companies) have a female CEO, CTO (Chief Technology Officer) or CSO (Chief Scientific Officer) which is the highest share to date.
Almost €196M will be provided to the selected companies combining grants and equity investments, which will be made through the EIC Fund. 94% of recommended funding is for beneficiaries in EU Member States, of which 17% is for widening country applicants.
The geographical focus of the winners spread across 14 countries, being the Netherlands (22%), Sweden (9%), Denmark (9%) and Ireland (9%) the countries on the top of the chart.
Fig. 1. Number of EIC winners per country
Most awarded projects belong to blended finance (17 out of 32 proposals, 53%), followed by grant first (12 out of 32 applications, 38%) and, finally, grant only (3 out of 32 proposals, 9%).
Figure 2: Share of winning projects by financing type
The 32 awarded projects can be classified into four categories: New deep-tech technologies & ICT; Health & Medical care; and Environment & Energy. Health has been the most awarded area with 19 out of 32 projects (59%), followed by new deep-tech technologies and ICT (8 out of 32 projects, 25%), and, finally, environment and energy (5 out of 32, 15.6%).
Figure 3: Share of winning projects by innovation area.
The table below includes the full list of winners:
|Company Name||Proposal Acronym||Short Description||Recommended Financing Type||Website||Country|
|Check Point Care Ltd||ARCHANGEL||Advanced Remote Continuous patient Health mANaGemEnt SoLution||Blended finance||www.checkpointcardio.com||Bulgaria|
|Tampon Innovations Ltd||VMS – Vaginal Microbiome Screening||Commercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon collection device and a digital layer to provide diagnosis, disease risk evaluation and aftercare.||Grant first||www.yourdaye.com||Bulgaria|
|SAMPLIX ApS||Cellularity||The critical shift to single-cell formats in functional analyses of living cells||Blended finance||www.samplix.com||Denmark|
|Kvantify Aps.||KvasirAccelerator||The first utility-oriented, agnostic software platform for quantum-centric drug discovery||Grant first||https://www.kvantify.dk/||Denmark|
|Bifrost Communications Aps||qc-rosa||a Quasi Coherent Receiver Optical Sub-Assembly technology for improved access networks||Blended finance||www.bifrostcommunications.com||Denmark|
|Pibond Oy||IO-PR||Silicon-Rich Materials for Advanced Semiconductor Fabrication||Grant first||www.pibond.com||Finland|
|CurifyLabs Oy||PMed||Enabling patient specific medicines using 3D printing in hospitals and pharmacies||Grant first||https://www.curifylabs.com/||Finland|
|SMART IMMUNE||Smart ProTcell||Smart Immune ProTcell: first-in-class allogeneic thymus empowered T cell therapy platform for fast and durable immune system reconstitution||Blended finance||https://www.smart-immune.com/||France|
|vorteX.io||WHYLD||Worlwide HYdrological Large-scale Database||Grant only||https://www.vortex-io.fr||France|
|Avelios Medical GmbH||Digitising Hospitals For Better Patient Care||First modular, interconnected, data- and AI-driven software platform for the digitisation of patient care in the healthcare industry||Grant only||https://avelios.com/||Germany|
|Hybrid Lidar Systems AG||LiSSA 3D||Next Generation LiDAR for Automotive and Industrial Use Cases||Blended finance||https://www.hybrid-lidar.com||Germany|
|Nemysis Ltd||Endoprotease 40 (E40)||First ever preventive treatment for celiac disease and gluten sensitivity||Grant first||https://nemysisltd.com/||Ireland|
|Versono Medical Limited||FASTWIRE||Transformational crossing system to prevent amputation and treat complex chronic total occlusions in critical limb ischemia||Grant first||https://www.versono.life/||Ireland|
|TECHNOLOGY FROM IDEAS LIMITED||TfI SeaSprings||Making access to the ocean affordable through our SeaSprings mooring solution||Blended finance||https://www.technologyfromideas.com/||Ireland|
|PARAGATE MEDICAL LTD||FILBERT||An innovative implantable device and management platform to prevent chronic fluid congestion||Blended finance||https://paragate-medical.com/||Israel|
|Naco Technologies||Naco Tech||Novel nano coating process to empower the green hydrogen revolution||Blended finance||www.naco.tech||Latvia|
|COVAL ENERGY BV||GAFT||Production of High-quality Fatty Acids Feedstock for use in SAF Production||Grant first||https://www.covalenergy.com/||Netherlands|
|inBiome B.V.||Molecular Culture||World’s first diagnostic test that can detect all bacterial species in a single assay||Grant first||https://inbiome.com/||Netherlands|
|Ocean Grazer B.V.||OCEANBATTERY||Unlocking the full potential of renewable energy with the Ocean Battery||Grant first||https://oceangrazer.com/||Netherlands|
|SentryX B.V.||OPERAS||Opioid-free Pain relief for Enhanced Recovery After Spine fixation surgery||Blended finance||https://sentryx.nl||Netherlands|
|INNATERA NANOSYSTEMS BV||Spiking Neural Processor||Always-On Intelligent Sensing with the Spiking Neural Processor||Blended finance||https://www.innatera.com/||Netherlands|
|STIL B.V||STABILIS||Stabilis – Providing relief for tremor patients||Blended finance||https://www.stilwearable.com/||Netherlands|
|VITESTRO BV||VD-1||The World’s First Autonomous Blood Drawing Device||Blended finance||https://vitestro.com/||Netherlands|
|BEIT Spolka z ograniczona odpowiedzialnoscia||COMFTQUA||Enabling efficient computation on fault tolerant quantum computers||Grant first||www.beit.tech||Poland|
|BAC3GEL, LDA.||Bac3Gel||New generation of substrates to harness the full power of microorganisms||Grant first||www.bac3gel.com||Portugal|
|iLoF – Intelligent Lab on Fiber, Lda||iLoF||Intelligent Lab on Fiber: AI-augmented photonics to identify and quantify disease biomarkers||Blended finance||https://ilof.tech/||Portugal|
|POLYFLY SL||HoverPollination||Hoverflies as a new class of managed pollinators for better quantitative and qualitative yields of vegetable, fruit and seed crops||Blended finance||http://polyfly.es/||Spain|
|MEDICSENSORS SL||SONOPHORESIS SMARTPATCH||Sonophoresis smartpatch for pain-free, controllable, and wearable transdermal drug delivery||Grant first||www.medicsen.com||Spain|
|Elonroad AB||Elonroad||On-the-go charging system for heavy electric vehicles in ports and other closed loop applications||Blended finance||https://elonroad.com/||Sweden|
|Nobula3D AB||NOBULA||Nobula – Breaking the glass ceiling in Additive Manufacturing through laser-assisted glass 3D printing||Blended finance||https://nobula3d.com/||Sweden|
|Inossia AB||SMART-SOFT||Inossia Cement Softener – a new and unique additive to bone cements to revolutionise the treatment of vertebral fractures in osteoporotic patients||Blended finance||http://www.inossia.com||Sweden|
|Momentum Bioscience Limited||SepsiSTAT||Disruptive diagnostic for bacterial infection directly from whole blood in patients with SEPSIS||Grant only||https://momentumbio.co.uk||United Kingdom|